Skip to main content

Table 3 Selected outcomes from the OPTIMIST-A follow-up study

From: The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25–28 weeks gestation

Number of hospitalisations in the first 2 years

Major disability at 2 years

Number of hospitalisations with respiratory illness in the first 2 years

Death or major disability at 2 years